• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基亚甲基二嗪烷的抗癌潜力I. 二嗪三酮芳基氨基亚甲基的合成及其在胶质母细胞瘤细胞中的细胞毒性作用测试

Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.

作者信息

Pianovich Nichole A, Dean Mathew, Lassak Adam, Reiss Krzysztof, Jursic Branko S

机构信息

Department of Chemistry, University of New Orleans, New Orleans, LA 70148, USA.

Neurological Cancer Research, Stanley S. Scott Cancer Center, Department of Medicine, LSU Health Sciences Center, New Orleans, LA 70119 USA.

出版信息

Bioorg Med Chem. 2017 Oct 1;25(19):5068-5076. doi: 10.1016/j.bmc.2017.08.020. Epub 2017 Aug 12.

DOI:10.1016/j.bmc.2017.08.020
PMID:28864149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5870872/
Abstract

Diazinane and aryl moieties with vinylamine linkers were synthesized to investigate the importance of their structural variations as potential anti-glioblastoma agents. Structural variations incorporated on to the diazinane moiety included oxa and thio derivatives, each with a variety of nitrogen-bound substituents. The size and shape of the aromatic moiety was varied, with the final variation introducing two carbonyl groups, yielding a substituted anthraquinone. Readily available diazinanes and aryl amines were used asan advantageous foundation. Several parameters were calculated whilst engineering these compounds, including: ClogP, molecular polarizability, polar surface area, minimal molecular projected area, and pK. In addition, a simple and efficient procedure was developed to synthesize these compounds. It was demonstrated that a vinylamine with 1,3-diazinane-2,4,6-trione and 1-anthraquinone moiety is the most promising drug candidate causing almost 70% of LN229 tumor cell death at 1µg/ml. In addition, its molecular polarizability, polar surface area and minimal molecular projected area indicate a possible potential of this molecule for crossing BBB.

摘要

合成了带有乙烯胺连接基的二嗪烷和芳基部分,以研究其结构变化作为潜在抗胶质母细胞瘤药物的重要性。引入到二嗪烷部分的结构变化包括氧杂和硫代衍生物,每种衍生物都有多种与氮相连的取代基。芳香部分的大小和形状有所不同,最后的变化引入了两个羰基,生成了一种取代蒽醌。易于获得的二嗪烷和芳基胺被用作有利的基础。在设计这些化合物时计算了几个参数,包括:脂水分配系数(ClogP)、分子极化率、极性表面积、最小分子投影面积和pK。此外,还开发了一种简单有效的方法来合成这些化合物。结果表明,带有1,3 - 二嗪烷 - 2,4,6 - 三酮和1 - 蒽醌部分的乙烯胺是最有前景的药物候选物,在1μg/ml时可导致近70%的LN229肿瘤细胞死亡。此外,其分子极化率、极性表面积和最小分子投影面积表明该分子有可能穿过血脑屏障。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/2d26f5f11721/nihms951351f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/29c4a647c768/nihms951351f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/0ba761ff70cd/nihms951351f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/b9eb84f633b0/nihms951351f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/129d3b08416d/nihms951351f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/92ca29f79a27/nihms951351f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/c08e37cf1ab1/nihms951351f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/0ee48d01c88d/nihms951351f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/2d26f5f11721/nihms951351f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/29c4a647c768/nihms951351f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/0ba761ff70cd/nihms951351f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/b9eb84f633b0/nihms951351f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/129d3b08416d/nihms951351f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/92ca29f79a27/nihms951351f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/c08e37cf1ab1/nihms951351f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/0ee48d01c88d/nihms951351f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a118/5870872/2d26f5f11721/nihms951351f8.jpg

相似文献

1
Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.氨基亚甲基二嗪烷的抗癌潜力I. 二嗪三酮芳基氨基亚甲基的合成及其在胶质母细胞瘤细胞中的细胞毒性作用测试
Bioorg Med Chem. 2017 Oct 1;25(19):5068-5076. doi: 10.1016/j.bmc.2017.08.020. Epub 2017 Aug 12.
2
Synthesis of N-aryl and N-arylcarbamoylamino derivatives of 1,3-diazinane-5-carboxamide and their activity against glioblastoma LN-229 cell line.1,3-二氮杂环己烷-5-甲酰胺的N-芳基和N-芳基氨基甲酰基氨基衍生物的合成及其对胶质母细胞瘤LN-229细胞系的活性。
Bioorg Med Chem. 2016 Dec 1;24(23):6183-6193. doi: 10.1016/j.bmc.2016.09.074. Epub 2016 Oct 4.
3
New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.新型1,4 - 蒽醌衍生物作为潜在的抗癌药物。
Farmaco. 2000 Jan;55(1):1-5. doi: 10.1016/s0014-827x(99)00091-9.
4
Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.阳离子蒽醌类似物的合成及其抗癌构效关系研究
Eur J Med Chem. 2014 Apr 22;77:96-102. doi: 10.1016/j.ejmech.2014.02.060. Epub 2014 Feb 28.
5
Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.新型双蒽醌衍生物的合成及其作为抗肿瘤剂的生物评价。
Arch Pharm Res. 2013 May;36(5):573-8. doi: 10.1007/s12272-013-0074-x. Epub 2013 Mar 8.
6
Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.1,3 - 二羟基 - 9,10 - 蒽醌衍生物的合成及其细胞毒性作用
Eur J Med Chem. 2000 Dec;35(12):1089-98. doi: 10.1016/s0223-5234(00)01190-9.
7
Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.新型氟卟啉-蒽醌配合物作为抗肿瘤剂的设计与合成
Chem Pharm Bull (Tokyo). 2016;64(9):1310-4. doi: 10.1248/cpb.c16-00308.
8
Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.羟基和3-烷基氨基丙氧基-9,10-蒽醌衍生物的设计、合成及细胞毒性作用
Bioorg Med Chem. 2005 May 16;13(10):3439-45. doi: 10.1016/j.bmc.2005.03.001.
9
Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.1,4-双(二甲氨基)-9,10-蒽醌衍生物的合成及其对 P388 白血病肿瘤细胞的抗增殖活性。
Arch Pharm Res. 2011 Jul;34(7):1071-6. doi: 10.1007/s12272-011-0704-0. Epub 2011 Aug 3.
10
Quinofuracins A-E, produced by the fungus Staphylotrichum boninense PF1444, show p53-dependent growth suppression.由真菌博宁葡萄穗霉PF1444产生的醌呋喃菌素A-E表现出p53依赖性生长抑制作用。
J Nat Prod. 2015 Feb 27;78(2):188-95. doi: 10.1021/np500581m. Epub 2015 Jan 22.

引用本文的文献

1
Glioblastoma: Current Status, Emerging Targets, and Recent Advances.胶质母细胞瘤:现状、新兴靶点及最新进展。
J Med Chem. 2022 Jul 14;65(13):8596-8685. doi: 10.1021/acs.jmedchem.1c01946. Epub 2022 Jul 5.

本文引用的文献

1
Synthesis of N-aryl and N-arylcarbamoylamino derivatives of 1,3-diazinane-5-carboxamide and their activity against glioblastoma LN-229 cell line.1,3-二氮杂环己烷-5-甲酰胺的N-芳基和N-芳基氨基甲酰基氨基衍生物的合成及其对胶质母细胞瘤LN-229细胞系的活性。
Bioorg Med Chem. 2016 Dec 1;24(23):6183-6193. doi: 10.1016/j.bmc.2016.09.074. Epub 2016 Oct 4.
2
Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.通过对流增强递送将聚合物纳米颗粒递送至脑肿瘤的分布情况。
J Control Release. 2016 Jun 28;232:103-12. doi: 10.1016/j.jconrel.2016.04.006. Epub 2016 Apr 8.
3
A Comparative Study of Molecular Structure, pKa, Lipophilicity, Solubility, Absorption and Polar Surface Area of Some Antiplatelet Drugs.
某些抗血小板药物的分子结构、pKa、亲脂性、溶解度、吸收及极性表面积的比较研究
Int J Mol Sci. 2016 Mar 19;17(3):388. doi: 10.3390/ijms17030388.
4
Finding the Therapeutic Sweet Spot: Using Naturally Occurring Human Variants to Inform Drug Design.寻找治疗的最佳平衡点:利用天然存在的人类变异来指导药物设计。
Circ Cardiovasc Genet. 2015 Oct;8(5):637-9. doi: 10.1161/CIRCGENETICS.115.001219.
5
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.药物如何进入细胞:经检验及可检验的预测,以助区分转运体介导的摄取与脂质双层扩散。
Front Pharmacol. 2014 Oct 31;5:231. doi: 10.3389/fphar.2014.00231. eCollection 2014.
6
Switch-loop flexibility affects transport of large drugs by the promiscuous AcrB multidrug efflux transporter.开关环柔韧性影响多特异性AcrB多药外排转运蛋白对大分子药物的转运。
Antimicrob Agents Chemother. 2014 Aug;58(8):4767-72. doi: 10.1128/AAC.02733-13. Epub 2014 Jun 9.
7
Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition.被动脂质扩散和载体介导的细胞摄取都是药物处置过程中膜渗透的重要机制。
Mol Pharm. 2014 Jun 2;11(6):1727-38. doi: 10.1021/mp400713v. Epub 2014 May 6.
8
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.贝伐珠单抗联合放疗-替莫唑胺治疗新诊断的胶质母细胞瘤。
N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345.
9
Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma.间变性星形细胞瘤患者的五年随访结果及替莫唑胺同步治疗复发性间变性星形细胞瘤的疗效
Asian J Neurosurg. 2012 Oct;7(4):181-90. doi: 10.4103/1793-5482.106650.
10
Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.分析分子极性表面描述符以预测血脑屏障通透性。
Int J Comput Biol Drug Des. 2013;6(1-2):146-56. doi: 10.1504/IJCBDD.2013.052195. Epub 2013 Feb 21.